HUP1100561A2 - Cocrystals for producing pharmaceutical compositions - Google Patents

Cocrystals for producing pharmaceutical compositions

Info

Publication number
HUP1100561A2
HUP1100561A2 HU1100561A HUP1100561A HUP1100561A2 HU P1100561 A2 HUP1100561 A2 HU P1100561A2 HU 1100561 A HU1100561 A HU 1100561A HU P1100561 A HUP1100561 A HU P1100561A HU P1100561 A2 HUP1100561 A2 HU P1100561A2
Authority
HU
Hungary
Prior art keywords
cocrystals
pharmaceutical compositions
producing pharmaceutical
producing
compositions
Prior art date
Application number
HU1100561A
Other languages
Hungarian (hu)
Inventor
Eva Dr Sipos
Lax Gyoergyi Kovanyine
Balazs Dr Volk
Jozsef Dr Barkoczy
Monika Mezoevari
Zoltan Varga
Andras Dancso
Original Assignee
Egis Gyogyszergyar Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyrt filed Critical Egis Gyogyszergyar Nyrt
Priority to HU1100561A priority Critical patent/HU230734B1/en
Priority to PCT/HU2012/000101 priority patent/WO2013054146A1/en
Publication of HUP1100561A2 publication Critical patent/HUP1100561A2/en
Publication of HU230734B1 publication Critical patent/HU230734B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
HU1100561A 2011-10-10 2011-10-10 Cocrystals of rivaroxaban for producing pharmaceutical compositions HU230734B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1100561A HU230734B1 (en) 2011-10-10 2011-10-10 Cocrystals of rivaroxaban for producing pharmaceutical compositions
PCT/HU2012/000101 WO2013054146A1 (en) 2011-10-10 2012-10-09 New co crystals useful in the preparation of pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1100561A HU230734B1 (en) 2011-10-10 2011-10-10 Cocrystals of rivaroxaban for producing pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUP1100561A2 true HUP1100561A2 (en) 2013-05-28
HU230734B1 HU230734B1 (en) 2017-12-28

Family

ID=89990468

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1100561A HU230734B1 (en) 2011-10-10 2011-10-10 Cocrystals of rivaroxaban for producing pharmaceutical compositions

Country Status (2)

Country Link
HU (1) HU230734B1 (en)
WO (1) WO2013054146A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
DK1934208T3 (en) 2005-10-04 2011-07-18 Bayer Schering Pharma Ag New polymorphic form of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) -phenyl] -1,3-oxazolidin-5-yl} -methyl ) -2-thiophenecarboxamide
DE102008028071A1 (en) 2008-06-12 2009-12-17 Bayer Schering Pharma Aktiengesellschaft New cocrystal compound of rivaroxaban and malonic acid
US20100168111A1 (en) 2008-12-31 2010-07-01 Apotex Pharmachem Inc. Polymorphic form of 5 chloro n {[(5s) 2 oxo 3 [4 (3 oxomorpholin 4 yl)phenyl]oxa-zolidin 5 yl]-methyl}thiophene 2 carboxamide

Also Published As

Publication number Publication date
WO2013054146A1 (en) 2013-04-18
HU230734B1 (en) 2017-12-28

Similar Documents

Publication Publication Date Title
AP3864A (en) Pharmaceutical composition
IL230010B (en) Inhalable pharmaceutical compositions
GB201113662D0 (en) Pharmaceutical compositions
ZA201308208B (en) Pharmaceutical compositions
HK1199824A1 (en) Pharmaceutical compositions
PL2776416T3 (en) Pharmaceutical compounds
SG11201400580VA (en) Pharmaceutical composition for inhalation
GB201118232D0 (en) Pharmaceutical composition
HK1201534A1 (en) Pharmaceutical compounds
HK1189158A1 (en) Pharmaceutical composition
GB201119799D0 (en) Pharmaceutical compounds
GB201113163D0 (en) Pharmaceutical compounds
GB201118181D0 (en) Pharmaceutical compositions
GB201118876D0 (en) Pharmaceutical compounds
EP2727593A4 (en) Nicorandil-containing pharmaceutical composition
EP2711010A4 (en) Pharmaceutical composition
HUP1100444A2 (en) Pharmaceutical composition
EP2714715A4 (en) Pharmaceutical compositions
PL2709599T3 (en) Pharmaceutical composition comprising drotaverine
HUP1100445A2 (en) Pharmaceutical composition
HUP1100561A2 (en) Cocrystals for producing pharmaceutical compositions
GB201105224D0 (en) Novel pharmaceutical compositions
EP2727594A4 (en) Novel pharmaceutical composition
GB201118874D0 (en) Pharmaceutical compounds
GB201118875D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees